{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:35:39Z","timestamp":1776620139218,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12032-020-01442-1","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T17:02:57Z","timestamp":1605978177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["SBRT in non-spine bone metastases: a literature review"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-3471","authenticated-orcid":false,"given":"Carolina","family":"De la Pinta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,21]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12724","author":"A Kougioumtzopoulou","year":"2017","unstructured":"Kougioumtzopoulou A, Zygogianni A, Liakouli Z, Kypraiou E, Kouloulias V. The role of radiotherapy in bone metastases: A critical review of current literature. Eur J Cancer Care (Engl). 2017. https:\/\/doi.org\/10.1111\/ecc.12724.","journal-title":"Eur J Cancer Care (Engl)."},{"key":"1442_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8\u201310.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1442_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5301\/tj.5000441","volume":"102","author":"S Ursino","year":"2016","unstructured":"Ursino S, Montrone S, Cantarella M, Menghini V, Matteucci F, Mazzotti V, Fiorica F, Fedele D, Erba P, Morganti R, Fabrini MG, Caramella D. Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes. Tumori. 2016;102(1):59\u201364. https:\/\/doi.org\/10.5301\/tj.5000441.","journal-title":"Tumori"},{"key":"1442_CR4","doi-asserted-by":"crossref","unstructured":"Owen D, Laack NN, Mayo CS, et al. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014; 4(2): e143ee149.","DOI":"10.1016\/j.prro.2013.05.006"},{"issue":"2","key":"1442_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.radonc.2018.03.030","volume":"127","author":"D Erler","year":"2018","unstructured":"Erler D, Brotherston D, Sahgal A, et al. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Radiother Oncol. 2018;127(2):304\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2018.03.030.","journal-title":"Radiother Oncol"},{"issue":"Suppl. 2","key":"1442_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/ajco.13115","volume":"15","author":"T Kam","year":"2019","unstructured":"Kam T, Chan O, Hung A, Yeung R. Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: results and pattern of failure. Asia-Pac J ClinOncol. 2019;15(Suppl. 2):14\u20139.","journal-title":"Asia-Pac J ClinOncol."},{"key":"1442_CR7","doi-asserted-by":"crossref","unstructured":"Napieralska A, Miszczyk L, Tukiendorf A, et al. The results of treatment of prostate cancer bone metastases after CyberKnife radiosurgery. Ortop Traumatol Rehabil. 2014; 16(3):339e349.","DOI":"10.5604\/15093492.1112535"},{"key":"1442_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13014-018-1096-9","volume":"13","author":"C Mercier","year":"2018","unstructured":"Mercier C, Dirix P, Meijnders P, Vermeulen P, Van Laere S, Debois H, Huget P, Verellen D. A phase I dose-escalation of stereotactic ablative body radiotherapy for non-spine bine and lymph node metastases (DESTROY-trial). Radiat Oncol. 2018;13:152.","journal-title":"Radiat Oncol"},{"key":"1442_CR9","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","volume":"21","author":"HL Yang","year":"2011","unstructured":"Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT MRI and bone scintigraphy. Eur Radiol. 2011;21:2604\u201317.","journal-title":"Eur Radiol"},{"key":"1442_CR10","doi-asserted-by":"crossref","unstructured":"Schmidt GP, Baur-Melnyk A. MRI of Bone Metastases. In Magnetic Resonance Imaging of the Bone Marrow. 2013; (pp. 73\u201390). Springer, Berlin","DOI":"10.1007\/174_2011_495"},{"issue":"2","key":"1442_CR11","first-page":"S147","volume":"6","author":"FM Prins","year":"2017","unstructured":"Prins FM, van der Velden JM, Gerlich AS, Kotte A, Eppinga W, Kasperts N, Verlaan J, Pameijer FA, Kerkmeijer L. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT. APM. 2017;6(2):S147\u201354.","journal-title":"APM"},{"key":"1442_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.clinimag.2015.07.012","volume":"39","author":"A Sikka","year":"2015","unstructured":"Sikka A, Adam SZ, Wood C, et al. Magnetic resonance imaging of pancreatic metastases from renal cell carcinoma. Clin Imaging. 2015;39:945\u201353.","journal-title":"Clin Imaging"},{"issue":"4","key":"1442_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2018.03.010","volume":"102","author":"S Raman","year":"2018","unstructured":"Raman S, Chin L, Erler D, Atenafu EG, Cheung P, Chu W, Chung H, Loblaw A, Poon I, Rubenstein J, Soliman H, Sahgal A, Tseng CL. Impact of magnetic resonance imaging on gross tumor volume delineation in non-spine bony metastasis treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(4):735\u201343.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1442_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.radonc.2017.08.030","volume":"126","author":"AS Gerlich","year":"2018","unstructured":"Gerlich AS, van der Velden JM, Kotte ANTJ, Tseng CL, Fanetti G, Eppinga WSC, Kasperts N, Intven MPW, Pameijer FA, Philippens MEP, Verkooijen HM, Seravalli E. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study. Radiother Oncol. 2018;126(3):534\u201340. https:\/\/doi.org\/10.1016\/j.radonc.2017.08.030.","journal-title":"Radiother Oncol"},{"issue":"6","key":"1442_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","volume":"5","author":"QN Nguyen","year":"2019","unstructured":"Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, Oreilly MS, Lewis VO. Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly non-spine bone metastases. A randomized Phase 2 Trial. JAMA Oncol. 2019;5(6):872\u20138.","journal-title":"JAMA Oncol."},{"issue":"20","key":"1442_CR16","first-page":"30056","volume":"S1879\u20138500","author":"TK Nguyen","year":"2020","unstructured":"Nguyen TK, Sahgal A, Dagan R, Eppinga W, Guckenberger M, Kim JH, Lo S, Redmond KJ, Siva S, Stish BJ, Tseng CS. Stereotactic body radiation therapy for nonspine bone metastases: International Practice Patterns to Guide Treatment Planning. Pract Radiat Oncol. 2020;S1879\u20138500(20):30056\u201364.","journal-title":"Pract Radiat Oncol"},{"key":"1442_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijrobp.2016.01.032","volume":"95","author":"JL Muldermans","year":"2016","unstructured":"Muldermans JL, Romak LB, Kwon ED, Park SS, Olivier KR. Stereotactic body radiation therapy for oligometastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2016;95:696\u2013702.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1442_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijrobp.2017.08.045","volume":"100","author":"K Ito","year":"2018","unstructured":"Ito K, Shimizuguchi T, Nihei K, et al. Patterns of intraosseous recurrence after stereotactic body radiation therapy for coxal bone metastasis. Int J Radiat Oncol Biol Phys. 2018;100:159\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1442_CR19","doi-asserted-by":"publisher","first-page":"9397","DOI":"10.2147\/CMAR.S186630","volume":"11","author":"M Loi","year":"2019","unstructured":"Loi M, Nuyttens J, Desideri I, Greto D, Livi L. Single-fraction radiotherapy (SFRT) for bone metastases: patient selection and perspectives. Cancer Manag Res. 2019;11:9397\u2013408.","journal-title":"Cancer Manag Res."},{"issue":"6","key":"1442_CR20","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.1111\/ecc.12915","volume":"27","author":"M Loi","year":"2018","unstructured":"Loi M, Klass ND, De Vries KC, et al. Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy. Eur J Cancer Care (Engl). 2018;27(6):e12915. https:\/\/doi.org\/10.1111\/ecc.12915.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1442_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3109\/0284186X.2011.652741","volume":"51","author":"PM Jhaveri","year":"2012","unstructured":"Jhaveri PM, Teh BS, Paulino AC, et al. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol. 2012;51:584\u20138 ([PubMed: 22248089]).","journal-title":"Acta Oncol"},{"issue":"6","key":"1442_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.prro.2019.07.005","volume":"9","author":"LA Gharzai","year":"2019","unstructured":"Gharzai LA, Beeler WH, Hayman JA, Mancini B, Jagsi R, Pierce L, Moran JM, Dominello MM, Boike T, Griffith K, Jolly S, Spratt DE, Michigan Radiation Oncology Quality Consortium. Recommendations for single-fraction radiation therapy and stereotactic body radiation therapy in palliative treatment of\u00a0bone\u00a0metastases: a\u00a0statewide practice patterns survey. Pract Radiat Oncol. 2019;9(6):541\u20138.","journal-title":"Pract Radiat Oncol."},{"key":"1442_CR23","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/foc.2003.15.2.7","volume":"15","author":"PC Gerszten","year":"2003","unstructured":"Gerszten PC, Ozhasoglu C, Burton SA, et al. CyberKnife frameless single-fraction stereotactic radiosurgery for tumors of the sacrum. Neurosurg Focus. 2003;15:E7.","journal-title":"Neurosurg Focus"},{"issue":"4","key":"1442_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ijrobp.2015.07.2288","volume":"93","author":"R McDonald","year":"2015","unstructured":"McDonald R, Probyn L, Poon I, Erler D, Brotherston D, Soliman H, Cheung P, Chung H, Chu W, Loblaw A, Thavarajah N, Lang C, Chin L, Chow E, Sahgal A. Tumor response after stereotactic body radiation therapy to nonspine bone metastases: an evaluation of response criteria. Int J Radiat Oncol Biol Phys. 2015;93(4):879\u201381. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.07.2288.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1442_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/neuros\/nyy393","volume":"85","author":"K Liang Zeng","year":"2019","unstructured":"Liang Zeng K, Myrehaug S, Soliman H, Tseng CL, Atenafu EG, Campbell M, Faruqi S, Lee YK, Ruschin M, Da Costa L, Yang V, Spears J, Heyn C, Maralani PJ, Whyne C, Yee A, Sahgal A. Stereotactic body radiotherapy for spinal metastases at the estreme ends of the spine: imaging-based outcomes for cervical and sacral metastases. Neurosurgery. 2019;85(5):605\u201312.","journal-title":"Neurosurgery."},{"issue":"5","key":"1442_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2016.03.022","volume":"95","author":"R Tao","year":"2016","unstructured":"Tao R, Bishop AJ, Brownlee Z, Allen PK, Settle SH, Chang EL, Wang X, Amini B, Tannir NM, Tatsui C, Rhines LD, Brown PD, Ghia AJ. Stereotactic body radiation therapy for spinal metastases in the postoperative setting: a secondary analysis of mature phase 1\u20132 trials. Int J Radiat Oncol Biol Phys. 2016;95(5):1405\u201313. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.022.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1442_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijrobp.2008.10.044","volume":"75","author":"A Hird","year":"2009","unstructured":"Hird A, Chow E, Zhang L, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys. 2009;75(1):193\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.044.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1442_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.03.022","volume":"86","author":"A Chiang","year":"2013","unstructured":"Chiang A, Zeng L, Zhang L, et al. Pain flare is a common adverse event in steroid-na\u00efve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(4):638\u201342. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.022.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1442_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ijrobp.2014.07.037","volume":"90","author":"HY Pan","year":"2014","unstructured":"Pan HY, Allen PK, Wang XS, Chang EL, Rhines LD, Tatsui CE, Ghia AJ. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1\/2 trials. Int J Radiat Oncol Biol Phys. 2014;90:870\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1442_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jbo.2014.10.001","volume":"3","author":"R McDonald","year":"2014","unstructured":"McDonald R, Chow E, Rowbottom L, DeAngelis C, Soliman H. Incidence of pain flare in radiation treatment of bone metastases: a literature review. J Bone Oncol. 2014;3:84\u20139.","journal-title":"J Bone Oncol"},{"issue":"4","key":"1442_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.clon.2008.12.010","volume":"21","author":"A Hird","year":"2009","unstructured":"Hird A, Zhang L, Holt T, Fairchild A, De Angelis C, Loblaw A, et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol (R Coll Radiol). 2009;21(4):329\u201335.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"1442_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13014-019-1359-0","volume":"14","author":"N Hardcastle","year":"2019","unstructured":"Hardcastle N, Hofman MS, Lee CY, Callhan J, Selbie L, Foroudi F, Shaw M, Chander S, Lim A, Chesson B, Murphy DG, Kron T, Siva S. NaF PET\/CT for Response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy. Radiat Oncol. 2019;14(1):164.","journal-title":"Radiat Oncol"},{"issue":"2","key":"1442_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.21037\/apm.2016.03.01","volume":"5","author":"N Chiu","year":"2016","unstructured":"Chiu N, Probyn L, Raman S, McDonald R, Poon I, Erler D, Brotherston D, Soliman H, Cheung P, Chung H, Chu W, Loblaw A, Thavarajah N, Lang C, Chin L, Chow E, Sahgal A. Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series. Ann Palliat Med. 2016;5(2):116\u201324.","journal-title":"Ann Palliat Med"},{"issue":"1099","key":"1442_CR34","doi-asserted-by":"publisher","first-page":"20181048","DOI":"10.1259\/bjr.20181048","volume":"92","author":"T Yu","year":"2019","unstructured":"Yu T, Choi CW, Kim KS. Treatment outcomes of stereotactic ablative radiation therapy for non-spinal bone metastases: focus on response assessment and treatment indication. Br J Radiol. 2019;92(1099):20181048. https:\/\/doi.org\/10.1259\/bjr.20181048.","journal-title":"Br J Radiol"},{"issue":"6","key":"1442_CR35","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1016\/j.prro.2015.05.004","volume":"5","author":"A Amini","year":"2015","unstructured":"Amini A, Altoos B, Bourlon MT, et al. Local control rates of metastatic renal cell carcinoma to the bone using stereotactic body radiation therapy: is RCC truly radioresistant? Pract Radiat Oncol. 2015;5(6):e589\u201396.","journal-title":"Pract Radiat Oncol"},{"key":"1442_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12885-017-3341-2","volume":"17","author":"G Habl","year":"2017","unstructured":"Habl G, Straube C, Schiller K, Duma MN, Oechsner M, Kessel KA, et al. Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT). BMC Cancer. 2017;17:361.","journal-title":"BMC Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01442-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-020-01442-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01442-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T16:37:45Z","timestamp":1606927065000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-020-01442-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,21]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1007\/s12032-020-01442-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,21]]},"assertion":[{"value":"29 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"119"}}